| AEREA Y POSTAL EX-IAAC | 2025 | 0.159 | KG | TRC-C366465-10MG-7-CHLORO-1-3-DIHYDRO-5-(2-FLUOROPHENYL)-2-NITROMETHY-LENE-2H-1,4-BENZODIA TRC-C366465-10MG-7-CHLORO-1-3-DIHYDRO-5-(2-FLUOROPHENYL)-2-NITROMETHY-LENE-2H-1,4-BENZODIA ESTANDARES PARA ANALISIS EN LABORATORIO DR: 2025283072 COI: 000305-2 | CANADA | GERMANY | 207.8 |
| AEREA Y POSTAL EX-IAAC | 2025 | 600 | KG | L-VALINE,N-(1-OXOPENTYL)-N-[[2-(1 H-TETRAZOL-5-YL), S/M, S/M L-VALINE,N-(1-OXOPENTYL)-N-[[2-(1 H-TETRAZOL-5-YL) [1,1-BIPHENYL]-4YL]METHYL] MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KILOS VALSARTAN/ T/T 90 DAYS FROM BL DATE | CHINA | CHINA | 22820.7 |
| AEREA Y POSTAL EX-IAAC | 2025 | 3 | KG | CALCIUM ( 2S)-2-[[4-[[[(6RS)-2-AMINO-5-FORMYL-4-OXO-1,4,5,6,7,8-HEXAHYDROPTERIDIN-6-YL]MET CALCIUM ( 2S)-2-[[4-[[[(6RS)-2-AMINO-5-FORMYL-4-OXO-1,4,5,6,7,8-HEXAHYDROPTERIDIN-6-YL]MET MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | CHINA | CHINA | 7814 |
| AEREA Y POSTAL EX-IAAC | 2025 | 2.5 | KG | 2,2-(5-(1H-1,2,4-TRIAZOL-1-YL)METHYL)-1,3-PHENYLENE)BIS(2-METHYLPROPANENITRILE), S/M, S/M 2,2-(5-(1H-1,2,4-TRIAZOL-1-YL)METHYL)-1,3-PHENYLENE)BIS(2-METHYLPROPANENITRILE) MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | CHINA | CHINA | 11995 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.18 | KG | (R)-((4-(1,4,5,6-TETRAHYDRO-4-METHYL-6-OXO-3-PYRIDAZINYL)PHENYL)HYDRAZONO) PROPANEDINITRIL (R)-((4-(1,4,5,6-TETRAHYDRO-4-METHYL-6-OXO-3-PYRIDAZINYL)PHENYL)HYDRAZONO) PROPANEDINITRIL MATERIA PRIMA PARA FABRICACIÓN DE MEDICAMENTOS COMERCIALIZADO EN GR | CZECH REPUBLIC | CZECH REPUBLIC | 7888.26 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.001 | KG | LEVOSIMENDAN, LGC, S/M LEVOSIMENDAN ... Estándar para análisis en laboratorio LEVOSIMENDAN | GERMANY | GERMANY | 2492 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.159 | KG | CLOMIPRAMINA IMPUREZA C, EP, S/M CLOMIPRAMINE IMPURITY C CRS ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO PRESENTACIÓN: 1 VIAL X 20 MG, Y0000132, LOTE: L03.00 30 DAYS END OF MONTH | FRANCE | FRANCE | 163.69 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.14 | KG | DEFERASIROX (EP), S/M, S/M DEFERASIROX (EP) ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO COMERCIALIZADO EN UNIDADES | FRANCE | FRANCE | 179.33 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.057 | KG | DEFERASIROX ADECUACION DEL SIST. A (EP), S/M, S/M DEFERASIROX FOR SYSTEM SUITABILITY A CRS COMERCIALIZADO EN UNIDADES ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO | FRANCE | FRANCE | 183.01 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.072 | KG | Zolpidem Related Compound A (15 mg) (N,NDimethyl-2-[7-methyl-2-p-tolylimidazo[1,2-a]pyridi Zolpidem Related Compound A (15 mg) (N,NDimethyl-2-[7-methyl-2-p-tolylimidazo[1,2-a]pyridi ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO CATALOG NUMBER: 17 | FRANCE | UNITED STATES | 903 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.038 | KG | Zolpidem Related Compound A (15 mg) (N,NDimethyl-2-[7-methyl-2-p-tolylimidazo[1,2-a]pyridi Zolpidem Related Compound A (15 mg) (N,NDimethyl-2-[7-methyl-2-p-tolylimidazo[1,2-a]pyridi ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO CATALOG NUMBER: 17 | FRANCE | UNITED STATES | 903 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.044 | KG | CLOMIPRAMINA IMPUREZA D, BP, S/M CLOMIPRAMINE IMPURITY D 10 MG ESTÁNDAR PARA ANÁLISIS EN LABORATORIO R.D. N° 566-2025/DIGEMID/DPF/EPC/MINSA - DR: 2025062661 | UNITED KINGDOM | SPAIN | 256.22 |